Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2026-08-18 17:34:08 ET · period of report 2026-08-14 · accession 0001193125-26-355735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 17:34 | 2026-08-14 | VRDN | Tripuraneni Radhika | Chief Medical Off | M - OptEx | $13.21 | +40.0K | 40.0K | New | +$528.4K |
| D | 2026-08-18 17:34 | 2026-08-14 | VRDN | Tripuraneni Radhika | Chief Medical Off | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | M | A | 40,000 | $13.21 | 40,000 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-08-14 | M | D | 40,000 | $0.00 | 0 | D | $13.21 · — to 2034-07-01 | 40,000 Common Stock | (F1) The option is fully vested. |